ESC 2019 Recommendations on Sotalol for Supraventricular Tachycardia (SVT)
1. Overall Recommendation (European Society of Cardiology)
- The 2019 ESC guidelines do not recommend sotalol for any SVT other than atrial fibrillation or atrial flutter; it carries a Class III (harm) recommendation (i.e., should not be used) 1.
- Sotalol is also Class III as a first‑line therapy for SVT in patients with adult congenital heart disease (ACHD) 1.
2. Specific Situations Where Sotalol Is Contra‑Indicated (ESC)
- Acute management – not recommended for wide‑QRS tachycardias, focal atrial tachycardia, AVRT, or AVNRT 2.
- Chronic treatment – not recommended for focal atrial tachycardia, AVRT, or AVNRT 2.
- Pregnancy – sotalol should not be used 2.
- Pre‑excited atrial fibrillation (WPW with AF) – use may precipitate ventricular fibrillation; therefore it is contraindicated 1.
3. Preferred Pharmacologic and Procedural Alternatives (ESC)
| Therapy | Indication | Recommendation Strength |
|---|---|---|
| Catheter ablation | First‑line definitive therapy for most SVTs | Class I (strongly recommended) [3] |
| Beta‑blockers | Acute management of narrow‑QRS tachycardias and AVRT | Recommended (upgraded from prior guidance) [1] |
| Adenosine | Drug of choice for acute SVT termination | Recommended (Class I) [2] |
| Flecainide / Propafenone | Chronic management when no structural heart disease | Class IIa (reasonable) [4] |
4. ACC/AHA/HRS 2015 Recommendations (American College of Cardiology / American Heart Association / Heart Rhythm Society)
- Sotalol may be reasonable (Class IIb) for ongoing management of symptomatic SVT only after beta‑blockers, diltiazem, or verapamil have failed or are contraindicated, and when catheter ablation is not feasible [4][5]6.
- The same Class IIb recommendation emphasizes that pro‑arrhythmic risk mandates reserving sotalol for patients who cannot undergo ablation and have exhausted first‑line agents [4][5].
5. Acute SVT Management Algorithm (ESC)
- Step 1: Vagal maneuvers [1][2]
- Step 2: Intravenous adenosine if vagal maneuvers fail [1][2]
- Step 3: Beta‑blocker for narrow‑QRS tachycardias [1][2]
- Step 4: Do NOT use sotalol (Class III) [1][2]
6. Chronic SVT Management Algorithm (Combined ESC & ACC/AHA/HRS)
- First choice: Catheter ablation (Class I) [1][3]
- If ablation not possible or declined: Beta‑blocker, diltiazem, or verapamil [4][5]
- If first‑line agents fail and no structural heart disease: Flecainide or propafenone (Class IIa) [4][5]
- Only consider sotalol when all above options have failed or are contraindicated (Class IIb) [4][5]
All bullet points are derived from guideline statements with the indicated citation IDs and include the strength of recommendation where provided.